| The economic burden of schizophrenia in the United States A Kadakia, M Catillon, Q Fan, GR Williams, JR Marden, A Anderson, ... The Journal of clinical psychiatry 83 (6), 43278, 2022 | 120 | 2022 |
| Two hundred years of health and medical care: The importance of medical care for life expectancy gains M Catillon, D Cutler, T Getzen National Bureau of Economic Research, 2018 | 38 | 2018 |
| Trends and predictors of biomedical research quality, 1990–2015: a meta-research study M Catillon BMJ open 9 (9), e030342, 2019 | 22 | 2019 |
| Who benefits most in disease management programs: Improving target efficiency T Simcoe, M Catillon, P Gertler Health economics 28 (2), 189-203, 2019 | 15 | 2019 |
| Medical knowledge synthesis: a brief overview M Catillon Research report, 2017 | 12 | 2017 |
| Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study KG Naber, F Wagenlehner, M Kresken, WY Cheng, M Catillon, MS Duh, ... Scientific Reports 13 (1), 12077, 2023 | 11 | 2023 |
| The economic burden of schizophrenia in the United States in 2019 A Kadakia, A Fan, J Marden, C Dembek, M Catillon, A Anderson, ... CNS spectrums 27 (2), 227-227, 2022 | 6 | 2022 |
| News coverage and drug shortages during the COVID-19 pandemic M Catillon, MS Majumder, SF Manzi, KD Mandl medRxiv, 2020.10. 12.20211656, 2020 | 6 | 2020 |
| Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine … J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, C Xu, D Chan, ... Journal of Managed Care & Specialty Pharmacy 30 (6), 528-540, 2024 | 3 | 2024 |
| Treatment preferences of adult patients with attention-deficit/hyperactivity disorder–A discrete choice experiment J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, Y Meng, ... Patient preference and adherence, 1651-1664, 2024 | 2 | 2024 |
| Quality of life and outcomes associated with adverse effects in pediatric patients with attention-deficit/hyperactivity disorder and their parents/caregivers J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, L Yu, B Libchaber, ... Journal of Child and Adolescent Psychopharmacology, 2024 | 1 | 2024 |
| Assessment of centanafadine in adults with ADHD: a matching adjusted indirect comparison versus methylphenidate hydrochloride extended release (Concerta) J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, C Xu, A Qu, ... Current Medical Research and Opinion 40 (8), 1397-1406, 2024 | 1 | 2024 |
| PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, Y Meng, ... Value in Health 27 (6), S310, 2024 | 1 | 2024 |
| Scrutiny for child abuse and neglect during the COVID-19 pandemic M Catillon, KD Mandl medRxiv, 2020.10. 12.20210997, 2020 | 1 | 2020 |
| On the Value of Biomedical Research and Medical Care M Catillon Harvard University, 2020 | 1 | 2020 |
| Two Hundred Years of Medical Care and Health M Catillon, D Cutler, T Getzen Technical report, National Bureau of Economic Research, 2018 | 1 | 2018 |
| Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, Y Meng, ... Neurology and Therapy, 1-18, 2024 | | 2024 |
| A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long … J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, C Xu, A Qu, F Lee, ... Journal of Comparative Effectiveness Research 13 (9), e240089, 2024 | | 2024 |
| Pegcetacoplan vs avacincaptad pegol in geographic atrophy: an anchored matching-adjusted indirect comparison of three phase 3 trials MA Zarbin, P Hahn, D Eichenbaum, D Dhoot, D Jones, M Intorcia, ... Investigative Ophthalmology & Visual Science 65 (7), 6487-6487, 2024 | | 2024 |
| PCR26 Impact of Attention-Deficit/Hyperactivity Disorder Treatment Adverse Effects on Quality of Life and Functioning of Pediatric Patients and Their Parents/Caregivers J Schein, M Cloutier, M Gauthier-Loiselle, M Catillon, L Yu, B Libchaber, ... Value in Health 27 (6), S300, 2024 | | 2024 |
Aditi KadakiaAbbvie在 abbvie.com 的电子邮件经过验证
